Contact Us
Actavis in the Americas
Actavis in Europe
Actavis in Asia-Pacific & MEA
Actavis’ global growth strategy is focused on three key principles: internal product development; strategic alliances; and select mergers/acquisitions of products, technologies and companies. As we expand our Actavis Pharma and Actavis Specialty Brands businesses -- with a focus on the U.S., Canada, and Latin America and other emerging markets – Actavis is committed to identifying opportunities that fit our capabilities, enhance our corporate goals and strengthen our competitive position. If you have an opportunity that you believe would be of interest to Actavis, please complete/submit the form below. We will respond to your request as soon as possible. You may also visit our Supplier Relations page if you would like more information about partnering with Actavis.
Actavis’ global growth strategy is focused on three key principles: internal product development; strategic alliances; and select mergers/acquisitions of products, technologies and companies.
As we expand our Actavis Pharma and Actavis Specialty Brands businesses -- with a focus on the U.S., Canada, and Latin America and other emerging markets – Actavis is committed to identifying opportunities that fit our capabilities, enhance our corporate goals and strengthen our competitive position.
If you have an opportunity that you believe would be of interest to Actavis, please complete/submit the form below. We will respond to your request as soon as possible.
You may also visit our Supplier Relations page if you would like more information about partnering with Actavis.
*Type of Product or Opportunity: Branded - Phase II or EarlierBranded - Phase III or Later, Not ApprovedBranded - ApprovedAuthorized GenericGenericActive Pharmaceutical IngredientOther
*Company:
*First Name:
*Last Name:
*Title:
*Address:
Address 2:
*City:
*State:
*Postal Code:
*Country: Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia And Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote D'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Terr. Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard And Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic Of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea Korea South Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts And Nevis Saint Lucia Saint Vincent And The Grenadines Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and S. Sandwich Is. Spain Sri Lanka St. Helena St. Pierre And Miquelon Sudan Suriname Svalbard And Jan Mayen Islands Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand The People's Repulic of China Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Minor Outlying Islands United States of America Unknown Uruguay Uzbekistan Vanuatu Venesuela Viet Nam Virgin Islands (British) Virgin Islands (U.S.) Wallis And Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe
*Phone:
Fax:
*Email Address:
This form is for Business Development Opportunities only. If you have a medical emergency requiring tablet or capsule identification, please contact your local poison control center or call 911. If you have questions regarding a Watson product, please contact us at 800-272-5525.
The information pertaining to you that we collect will be used in accordance with our Privacy Policy.